drugset / Trial / NCT00267332

Modafinil in Opioid Induced Sedation

NCT00267332

RandomizedCrossoverDouble-blindTreatment

Summary

* The primary objective of this study is to evaluate the efficacy of modafinil in the treatment of opioid induced sedation as measured by the Epworth Sleepiness Scale (ESS). * The secondary objective is to estimate the frequency and severity of toxicity associated with Modafinil (400mg) in patients with opioid induced sedation.

Timeline

Start
2006-01
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Modafinil Small molecule 400 mg

Indications